ABO 103
Alternative Names: ABO-103Latest Information Update: 03 Aug 2023
At a glance
- Originator Arbor Biotechnologies
- Class Gene therapies
- Mechanism of Action Gene silencing
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Liver disorders
Most Recent Events
- 18 Jul 2023 Early research in Liver disorders in USA (Parenteral) (Arbor Biotechnologies pipeline, July 2023)